Las Vegas, NV (PRWEB) January 08, 2014
GERO Corporation today announced the launch of a collaborative effort within the Human Locomotome project to gather and analyze the data of 50,000 Fitbit, Jawbone, and Nike Fuelband users to advance early detection of chronic disease. Chronic diseases are the leading source of health care spending in the United States.
"Locomotor activity, measured by wearable accelerometers, has recently emerged as the single source of an unprecedented volume of continuous high-resolution data characterizing the day-to-day, around-the-clock physiological conditions of millions of people," said Vera Kozyr, co-founder of GERO. "We launched the Human Locomotome project together with our scientists to develop technology for early stage diagnostics by analyzing movement activity. We hope to make the information stable, reliable and accessible."
GERO Lab is a proprietary "crowd-research" wearable 2.0 platform used to collect data and involve people and partners in the study. Ultimately, the GERO Lab platform could help existing activity trackers improve product compliance.
GERO Lab will be able to take advantage of the expected growth in the wearable fitness devices market, expected to reach 90 million units globally by 2017, and another 80 million health-related ones, according to leading research firm ABI (Source: February 2012).
GERO recently conducted a study with 3000 Fitbit users, which confirmed the great potential for the GERO platform. Key takeaways of this study include:
Motor activity contains signatures of particular chronic deceases (metabolic, psychiatric, psychological).
Low-resolution trackers (e.g. Fitbit, Jawbone, etc) can also be used with GERO's mathematical model with sufficient tracking time.
GERO already detects particular health conditions with accuracy.
People who want to contribute their da
Copyright©2012 Vocus, Inc.
All rights reserved